Ignite Creation Date:
2024-05-05 @ 4:56 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00345345
Status:
COMPLETED
Last Update Posted:
2022-05-03
First Post:
2006-06-27
Brief Title:
Alemtuzumab Campath to Treat T-Large Granular Lymphocyte Leukemia
Sponsor:
Organization:
National Institutes of Health Clinical Center CC